Bio Medica Laboratories was originally incorporated as a private limited company with the name of ‘Bio Medica Laboratories Private Limited’ under the Companies Act, 2013 vide certificate of incorporation dated August 14, 2015, issued by Registrar of Companies, Gwalior. Further, the company was converted into a Public Limited Company in pursuance of a special resolution passed by the members of the Company at the Extra- Ordinary General Meeting held on September 09, 2024 & name of the company changed from ‘Bio Medica Laboratories Private Limited’ to ‘Bio Medica Laboratories Limited’ & Registrar of Companies, CPC has issued a new certificate of incorporation consequent upon conversion dated October 24, 2024.

Bio Medica Laboratories is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The company operates on a B2B business model through contract manufacturing and does not deal directly with the end users. The company manufactures formulations for various companies according to their specific requirements and specifications for the type of formulation needed. Additionally, it enters into agreements with them, allowing their name and address to be displayed on the packaging as ‘Technical Collaborator’ or ‘marketed by’ alongside the company’s name as the manufacturer.

The company holds Good Manufacturing Practices (GMP) certificate issued by Food & Drugs Administration, Madhya Pradesh, for complying with established GMP standards and guidelines. The company maintain stringent quality control standards throughout the entire manufacturing process. 

Business area of the company

Bio Medica Laboratories is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences.

Products of the company

Liquid injectables

• 100ml Amikacin Sulphate IP injection
• Vitamin B12, D3 & Calcium Gluconolactobionate injection
• 2ml Amikacin Sulphate injection
• Buprenorphine injection
• 30ml Amikacin Sulphate injection

Dry Powder Injectables

• Piperacillin & Tazobactam injection
• Ceftrixone & Sulbactam for injection
• Meropenem injection
• Ceftriaxone injection
• Artesunate injection

History and milestones

• 2015: Incorporation of Company.
• 2024: Alteration of Name clause of Memorandum of Association and subsequently Conversion of the Company from Private Limited Company into Public Limited Company.